Literature DB >> 12109348

Timing hormonal therapy in prostate cancer.

Annette E Sessions1, Edward M Messing.   

Abstract

The history of the use of hormonal therapy to treat prostrate cancer is outlined, focusing on such treatments and disease scenarios as diethylstilboestrol therapy, androgen ablation alone or in conjunction with radiation, and the treatment of minimal disease burdens. Studies have pointed to the benefits of initiating androgen ablation therapy earlier in the treatment of prostate cancer; the greatest benefits of anti-androgen therapy may be gained when only tiny amounts of prostate cancer are present.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109348     DOI: 10.1016/s0094-0143(02)00007-1

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  1 in total

1.  Prostate cancer update: advanced disease.

Authors:  Michael A Carducci
Journal:  Rev Urol       Date:  2003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.